RLMD – relmada therapeutics, inc. (US:NASDAQ)

News

Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
Relmada Therapeutics to Present at Jefferies London Healthcare Conference [Yahoo! Finance]
Relmada Therapeutics to Present at Jefferies London Healthcare Conference
Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease [Yahoo! Finance]
Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com